Current status of tissue markers as prognostic factors in prostatic adenocarcinoma.
Hammond
E H
EH
Grignon
D J
DJ
D000230:Adenocarcinoma / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D014408:Biomarkers, Tumor / Q000032:analysis*; D004273:DNA, Neoplasm / Q000032:analysis; D005434:Flow Cytometry / Q000379:methods; D016158:Genes, p53; D006801:Humans; D008297:Male; D009154:Mutation; D009367:Neoplasm Staging; D009857:Oncogenes; D011003:Ploidies; D011237:Predictive Value of Tests; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000032:analysis; D011471:Prostatic Neoplasms / Q000235:genetics / Q000473:pathology* / Q000628:therapy
D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D017430:Prostate-Specific Antigen